Washington, D.C. – Adviser Warns President Trump’s Medications May Be Affecting Energy and Cognition

A British cardiologist and adviser to Health Secretary Robert F. Kennedy Jr., Dr. Aseem Malhotra, has raised concerns that President Donald Trump, 79, may be experiencing fatigue and cognitive slowing due to his cholesterol medications and aspirin. Speaking at a European Parliament event for the new health advocacy organization Make Europe Healthy Again (MEHA), Malhotra questioned the benefit of statins for older adults without cardiovascular disease.

“President Trump is taking statins; he’s on two cholesterol drugs… This man does not have any cardiovascular disease,” Malhotra said. He added that for individuals over 75 with no prior heart disease, statins provide minimal benefit, estimating that 446 people would need to take the medication to prevent one cardiovascular event.

Concerns Over Side Effects

Malhotra, a controversial figure known for his skepticism toward vaccines and cholesterol treatments, suggested that the president’s reported fatigue, occasional confusion, and slowed movements could be side effects of statins, which are known to cause muscle pain, fatigue, and “brain fog” in some patients. He proposed that discontinuing statins and aspirin could improve energy levels within weeks, though these claims are debated among medical experts.

Speculation About Trump’s Health

President Trump’s physical and mental health has been under public scrutiny, with some commentators noting minor gaffes, bruising, and swollen ankles. Despite speculation about cognitive decline, the White House maintains that Trump is in excellent overall health. A recent check-up at Walter Reed Medical Center reportedly confirmed his physical fitness, with officials emphasizing his golfing ability and “mental acuity and energy levels that most young people could not fathom having.”

The White House also clarified that Trump’s bruised hands are a result of frequent handshaking and his aspirin regimen for cardiovascular protection. Additionally, he has been diagnosed with chronic venous insufficiency, a non-life-threatening condition common in older adults.

Medical and Public Response

Malhotra’s comments have drawn criticism due to his controversial views on vaccines and statins, which many experts consider misleading or unproven. Statins remain widely prescribed and clinically recommended for individuals at risk of heart disease, with documented benefits for cardiovascular prevention. Recent research also shows that COVID-19 vaccines, which Trump has received, continue to provide strong protection against severe illness and death, especially for those over 65.

The Food and Drug Administration (FDA) previously noted in 2012 that statins may rarely cause reversible memory impairment, though there is no evidence linking statins to dementia. Trump’s physicians continue to manage his high cholesterol with rosuvastatin and ezetimibe, alongside low-dose aspirin, as part of standard treatment.

Conclusion

While concerns about Trump’s energy levels and cognitive function persist in public discourse, the White House insists that the president remains vigorous and alert. Malhotra’s remarks contribute to ongoing debate over the effects of statins and aspirin in older adults, highlighting the intersection of medication management and public perception of presidential health.